EN
CN
TC
Home
About Us
Company Introduction
→
Development History
→
Management Team
→
Science
Therapeutic Area
→
Pipeline
→
Our Platform
→
Publication
→
News
Careers
Culture And Welfare
→
Job Recruitment
→
EN
CN
TC
Search
Contact
Home
About Us
Back List
About Us
Company Introduction
→
Development History
→
Management Team
→
Science
Back List
Science
Therapeutic Area
→
Pipeline
→
Our Platform
→
Publication
→
News
Careers
Back List
Careers
Culture And Welfare
→
Job Recruitment
→
Contact
News
News
What’s New in the World of Atheron?
2026-09-08
Atheron Successfully Included in 2026 Shanghai Tech SMEs
2026-06-16
Atheron Unveils MRGPRX2 Inhibitor ATH-004 at EAACI, Advancing to Global Stage
2026-06-11
Atheron Announces Upcoming Presentation for Preclinical Portfolio at The European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2026
2026-03-20
Atheron Announces Upcoming Presentation for Preclinical Oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
2026-03-19
Atheron Therapeutics announced that it will present update on the advancement of MRGPRX2 program at the upcoming European Academy of Allergy and Clinical Immunology conference (EAACI)
2026-02-27
Atheron Highlights Data to be Presented at AACR Congress 2026
